Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 nov. 2019 09h00 HE | Source: Quotient Limited

Quotient Limited to Participate in the Jefferies 2019 London Healthcare Conference

JERSEY, Channel Islands, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Executive Officer,...
12 nov. 2019 16h05 HE | Source: Quotient Limited

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the closing of its previously...
06 nov. 2019 22h00 HE | Source: Quotient Limited

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously...
06 nov. 2019 16h20 HE | Source: Quotient Limited

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an...
04 nov. 2019 06h00 HE | Source: Quotient Limited

Quotient Limited Provides Positive Updates on MosaiQ’s Initial Serological Disease Screening and Expanded Immunohematology Microarrays, on Hypercare Launch and on a Successful Facility Audit and Reports Second Quarter Fiscal 2020 Financial Results

Positive results from the initial Serological Disease Screening microarray US field trialPositive Verification and Validation data for expanded Immunohematology microarrayAn additional three Hypercare...
31 oct. 2019 08h00 HE | Source: Quotient Limited

Quotient Announces Positive Preliminary Results from the Initial Serological Disease Screening US Field Trial

JERSEY, Channel Islands, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced positive preliminary US field trial data on the...
21 oct. 2019 06h00 HE | Source: Quotient Limited

Quotient Limited to Report Second Quarter 2020 Financial Results and Host Conference Call

JERSEY, Channel Islands, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second...
17 oct. 2019 16h51 HE | Source: Quotient Limited

Quotient Announces Positive Verification and Validation Results for Extended Immunohematology Microarray and Updates on Hypercare Sites and Revenue Performance in the Quarter

Successful Extended Immunohematology Verification and Validation data paving the way for field trialsPositive customer feedback and three additional hypercare sites initiatedPreliminary quarterly...
05 août 2019 06h15 HE | Source: Quotient Limited

Quotient Limited Provides Updates on European Hypercare Launch, the CE Mark Submission and U.S. Field Trial for the Initial Serological Disease Screening Microarray, and Reports First Quarter Fiscal 2020 Results

First European hypercare launch site initiated following CE mark approvalInitial Serological Disease Screening microarray submitted for CE marking U.S. field trial activities for initial Serological...
22 juil. 2019 08h00 HE | Source: Quotient Limited

Quotient Limited to Report First Quarter 2020 Financial Results and Host Conference Call

JERSEY, Channel Islands, July 22, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter...

Page précédente